Lamiken-R宫颈扩张棒的临床研究

发布时间：2018-05-09 22:43

本文选题：Lamiken-R宫颈扩张棒 + 宫颈扩张　；参考：《中国妇产科临床杂志》2017年04期

【摘要】：目的探讨Lamiken-R宫颈扩张棒用于宫腔手术前扩张宫颈的临床疗效及副作用。方法选择宫内节育器、妊娠10周内负压吸引人工流产术、宫腔镜检查及手术的患者130例,抽签法随机分为两组,研究组(63例)术前1~2 h宫颈内口放置Lamiken-R宫颈扩张棒;对照组(67例)术前3 h于阴道后穹隆放置米索前列醇0.4 mg。以宫颈无阻力通过Hegar宫颈扩张棒的号码评估宫颈松弛程度,观察两组宫颈扩张效果及副反应。结果研究组成功置入60例,成功率95.2%(60/63);研究组育龄非孕期通过宫颈扩张棒的号码为(8.07±0.73)号,对照组为(6.39±0.93)号;研究组绝经期通过宫颈扩张棒的号码为(7.47±0.74)号,对照组为(5.00±0.82)号;研究组妊娠早期通过宫颈扩张棒的号码为(7.85±0.63)号,对照组为(5.95±0.89)号;研究组宫颈扩张效果优于对照组(P0.01)。研究组发生恶心呕吐、腹痛、腹泻、阴道出血及发热率明显低于对照组(P0.01);两组术后体温正常,无一例发生感染。结论 Lamiken-R宫颈扩张棒用于宫腔手术前扩张宫颈效果显著,不良反应少,优于传统的米索前列醇,对女性不同时期扩张宫颈口均有效,值得临床推广应用。
[Abstract]:Objective to investigate the clinical efficacy and side effects of Lamiken-R dilatator for cervical dilatation before intrauterine surgery. Methods 130 patients with intrauterine device, suction induced abortion under negative pressure in 10 weeks of pregnancy, hysteroscopy and operation were randomly divided into two groups: study group (n = 63) and cervical dilatation rod (Lamiken-R) was placed at the intrauterine orifice 1 hour before operation. In the control group (67 cases), 0.4 mg of misoprostol was placed in the posterior vagina fornix 3 h before operation. The degree of cervix relaxation was evaluated by the number of cervical dilatator Hegar without cervical resistance, and the effect and side effects of cervical dilatation were observed. Results 60 cases were successfully implanted in the study group, the success rate was 95.2um 60 / 63, the number of cervical dilatator was 8.07 卤0.73) in the study group and 6.39 卤0.93 in the control group, and the number of the cervical dilatator was 7.47 卤0.74 in the study group and 5.00 卤0.82 in the control group. The number of cervical dilatator was 7.85 卤0.63 in the study group and 5.95 卤0.89 in the control group, and the effect of cervical dilatation in the study group was better than that in the control group. The rates of nausea and vomiting, abdominal pain, diarrhea, vaginal hemorrhage and fever in the study group were significantly lower than those in the control group (P 0.01). Conclusion Lamiken-R is more effective than misoprostol in dilating cervix before intrauterine surgery, and it is worth popularizing in clinic.
【作者单位】：首都医科大学附属北京天坛医院妇产科;
【分类号】：R169.42

【相似文献】